LBA67Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study. (23rd October 2018) - Italiano, A; Penel, N; Toulmonde, M; Bompas, E; Piperno-Neumann, S; Pulido, M; Entz-Werle, N; Le Cesne, A; Chevreau, C M; Duffaud, F; Ray-Coquard, I L; Bellera, C; et al.